Lycopene Prevents Mitochondrial Dysfunction during d‑Galactosamine/Lipopolysaccharide-Induced Fulminant Hepatic Failure in Albino Rats

Functional perturbation of mitochondria is associated with fulminant hepatic failure (FHF). d-Galactosamine/lipopolysaccharide (d-GalN/LPS)-induced FHF is a renowned model to evaluate the efficacy of hepatoprotective agents. Lycopene is an antioxidant and phytonutrient from the carotenoid family. Th...

Full description

Saved in:
Bibliographic Details
Published inJournal of proteome research Vol. 16; no. 9; pp. 3190 - 3199
Main Authors Sheriff, Sheik Abdulazeez, Shaik Ibrahim, Shaikhussain, Devaki, Thiruvengadam, Chakraborty, Sandipan, Agarwal, Subhash, Pérez-Sánchez, Horacio
Format Journal Article
LanguageEnglish
Published United States American Chemical Society 01.09.2017
Subjects
ATP
Online AccessGet full text

Cover

Loading…
Abstract Functional perturbation of mitochondria is associated with fulminant hepatic failure (FHF). d-Galactosamine/lipopolysaccharide (d-GalN/LPS)-induced FHF is a renowned model to evaluate the efficacy of hepatoprotective agents. Lycopene is an antioxidant and phytonutrient from the carotenoid family. The health benefits of lycopene are prominent against cancer and cardiovascular, lung, liver, and skin problems. Recent studies have demonstrated the hepatoprotective, antidyslipidemic, and antioxidant roles of lycopene. The current study was designed to appraise the ability of lycopene to prevent mitochondrial dysfunction during the d-GalN/LPS-induced FHF. The administration of d-GalN/LPS (300 mg and 30 μg/kg body weight, respectively) to the experimental rats induced several disturbances in mitochondrial function. The lipid peroxide and hydrogen peroxide levels were increased (p < 0.05). The activities of mitochondrial antioxidants, tricarboxylic acid (TCA) cycle, and electron transport chain enzymes and the cellular adenosine triphosphate (ATP) content were decreased (p < 0.05). Lycopene (10 mg/kg body weight for 6 days) pretreatment attenuated lipid peroxidation and prohibited the excessive synthesis of hydrogen peroxide. The d-GalN/LPS-induced impairment in ATP production and increased enzyme activities were effectively prevented by the lycopene administration. The lycopene-mediated mitochondrial protection was mainly ascribed to the strong antioxidant potential of this phytonutrient. Molecular modeling results obtained show evidence that lycopene inhibits several lipoxygenases and provides rationale for the observed prevention of lipid peroxidation in the mitochondrial membrane. The carotenoid lycopene combatted oxidative stress, scavenged free radicals, prevented ROS generation, and inhibited the toxic effects of d-GalN/LPS during FHF.
AbstractList Functional perturbation of mitochondria is associated with fulminant hepatic failure (FHF). d-Galactosamine/lipopolysaccharide (d-GalN/LPS)-induced FHF is a renowned model to evaluate the efficacy of hepatoprotective agents. Lycopene is an antioxidant and phytonutrient from the carotenoid family. The health benefits of lycopene are prominent against cancer and cardiovascular, lung, liver, and skin problems. Recent studies have demonstrated the hepatoprotective, antidyslipidemic, and antioxidant roles of lycopene. The current study was designed to appraise the ability of lycopene to prevent mitochondrial dysfunction during the d-GalN/LPS-induced FHF. The administration of d-GalN/LPS (300 mg and 30 μg/kg body weight, respectively) to the experimental rats induced several disturbances in mitochondrial function. The lipid peroxide and hydrogen peroxide levels were increased (p < 0.05). The activities of mitochondrial antioxidants, tricarboxylic acid (TCA) cycle, and electron transport chain enzymes and the cellular adenosine triphosphate (ATP) content were decreased (p < 0.05). Lycopene (10 mg/kg body weight for 6 days) pretreatment attenuated lipid peroxidation and prohibited the excessive synthesis of hydrogen peroxide. The d-GalN/LPS-induced impairment in ATP production and increased enzyme activities were effectively prevented by the lycopene administration. The lycopene-mediated mitochondrial protection was mainly ascribed to the strong antioxidant potential of this phytonutrient. Molecular modeling results obtained show evidence that lycopene inhibits several lipoxygenases and provides rationale for the observed prevention of lipid peroxidation in the mitochondrial membrane. The carotenoid lycopene combatted oxidative stress, scavenged free radicals, prevented ROS generation, and inhibited the toxic effects of d-GalN/LPS during FHF.
Functional perturbation of mitochondria is associated with fulminant hepatic failure (FHF). d-Galactosamine/lipopolysaccharide (d-GalN/LPS)-induced FHF is a renowned model to evaluate the efficacy of hepatoprotective agents. Lycopene is an antioxidant and phytonutrient from the carotenoid family. The health benefits of lycopene are prominent against cancer and cardiovascular, lung, liver, and skin problems. Recent studies have demonstrated the hepatoprotective, antidyslipidemic, and antioxidant roles of lycopene. The current study was designed to appraise the ability of lycopene to prevent mitochondrial dysfunction during the d-GalN/LPS-induced FHF. The administration of d-GalN/LPS (300 mg and 30 μg/kg body weight, respectively) to the experimental rats induced several disturbances in mitochondrial function. The lipid peroxide and hydrogen peroxide levels were increased (p < 0.05). The activities of mitochondrial antioxidants, tricarboxylic acid (TCA) cycle, and electron transport chain enzymes and the cellular adenosine triphosphate (ATP) content were decreased (p < 0.05). Lycopene (10 mg/kg body weight for 6 days) pretreatment attenuated lipid peroxidation and prohibited the excessive synthesis of hydrogen peroxide. The d-GalN/LPS-induced impairment in ATP production and increased enzyme activities were effectively prevented by the lycopene administration. The lycopene-mediated mitochondrial protection was mainly ascribed to the strong antioxidant potential of this phytonutrient. Molecular modeling results obtained show evidence that lycopene inhibits several lipoxygenases and provides rationale for the observed prevention of lipid peroxidation in the mitochondrial membrane. The carotenoid lycopene combatted oxidative stress, scavenged free radicals, prevented ROS generation, and inhibited the toxic effects of d-GalN/LPS during FHF.Functional perturbation of mitochondria is associated with fulminant hepatic failure (FHF). d-Galactosamine/lipopolysaccharide (d-GalN/LPS)-induced FHF is a renowned model to evaluate the efficacy of hepatoprotective agents. Lycopene is an antioxidant and phytonutrient from the carotenoid family. The health benefits of lycopene are prominent against cancer and cardiovascular, lung, liver, and skin problems. Recent studies have demonstrated the hepatoprotective, antidyslipidemic, and antioxidant roles of lycopene. The current study was designed to appraise the ability of lycopene to prevent mitochondrial dysfunction during the d-GalN/LPS-induced FHF. The administration of d-GalN/LPS (300 mg and 30 μg/kg body weight, respectively) to the experimental rats induced several disturbances in mitochondrial function. The lipid peroxide and hydrogen peroxide levels were increased (p < 0.05). The activities of mitochondrial antioxidants, tricarboxylic acid (TCA) cycle, and electron transport chain enzymes and the cellular adenosine triphosphate (ATP) content were decreased (p < 0.05). Lycopene (10 mg/kg body weight for 6 days) pretreatment attenuated lipid peroxidation and prohibited the excessive synthesis of hydrogen peroxide. The d-GalN/LPS-induced impairment in ATP production and increased enzyme activities were effectively prevented by the lycopene administration. The lycopene-mediated mitochondrial protection was mainly ascribed to the strong antioxidant potential of this phytonutrient. Molecular modeling results obtained show evidence that lycopene inhibits several lipoxygenases and provides rationale for the observed prevention of lipid peroxidation in the mitochondrial membrane. The carotenoid lycopene combatted oxidative stress, scavenged free radicals, prevented ROS generation, and inhibited the toxic effects of d-GalN/LPS during FHF.
Author Sheriff, Sheik Abdulazeez
Pérez-Sánchez, Horacio
Agarwal, Subhash
Shaik Ibrahim, Shaikhussain
Devaki, Thiruvengadam
Chakraborty, Sandipan
AuthorAffiliation Universidad Católica San Antonio de Murcia (UCAM)
Department of Computer Science and Engineering
Department of Microbiology
Bioinformatics Division
University of Calcutta
Bioinformatics and High Performance Computing Research Group (BIO-HPC), Computer Engineering Department
Department of Biochemistry
National Institute of Cancer Prevention and Research (NICPR-ICMR)
Government College of Engineering
AuthorAffiliation_xml – name: National Institute of Cancer Prevention and Research (NICPR-ICMR)
– name: Government College of Engineering
– name: Bioinformatics Division
– name: Bioinformatics and High Performance Computing Research Group (BIO-HPC), Computer Engineering Department
– name: Department of Computer Science and Engineering
– name: Universidad Católica San Antonio de Murcia (UCAM)
– name: Department of Microbiology
– name: University of Calcutta
– name: Department of Biochemistry
Author_xml – sequence: 1
  givenname: Sheik Abdulazeez
  surname: Sheriff
  fullname: Sheriff, Sheik Abdulazeez
  email: biosherif@yahoo.co.in
  organization: Department of Biochemistry
– sequence: 2
  givenname: Shaikhussain
  surname: Shaik Ibrahim
  fullname: Shaik Ibrahim, Shaikhussain
  organization: Government College of Engineering
– sequence: 3
  givenname: Thiruvengadam
  surname: Devaki
  fullname: Devaki, Thiruvengadam
  organization: Department of Biochemistry
– sequence: 4
  givenname: Sandipan
  surname: Chakraborty
  fullname: Chakraborty, Sandipan
  organization: University of Calcutta
– sequence: 5
  givenname: Subhash
  surname: Agarwal
  fullname: Agarwal, Subhash
  organization: National Institute of Cancer Prevention and Research (NICPR-ICMR)
– sequence: 6
  givenname: Horacio
  surname: Pérez-Sánchez
  fullname: Pérez-Sánchez, Horacio
  email: hperez@ucam.edu
  organization: Universidad Católica San Antonio de Murcia (UCAM)
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28758404$$D View this record in MEDLINE/PubMed
BookMark eNqFkctu1DAUhi1U1PsjgLxkk6kvSRyLVVWYttIgEKJry3FOqKvEDraDNDuWbHnFPkk9zAwLNrPykfz950jff4aOnHeA0BtKFpQweqVNXDxNwSfwIyxESwgV9St0SiteFVwScbSfG8lP0FmMTxmpBOHH6IQ1ompKUp6i36u18RM4wF8C_ASXIv5kkzeP3nXB6gF_WMd-diZZ73A3B-u-4-75159bPWiTfNSjdXC1spOf_LCO2phHHWwHxb3rZgMdXs5DRrRL-A4mnazBS22HOQC2Dl8PrXUef9UpXqDXvR4iXO7ec_Sw_Pjt5q5Yfb69v7leFZo3ZSpM09a9JBx4WbedgUoSBlJ2wCitpGZCCAOUGN1LyaToQUJVb3TUbSPbWvBz9G67N7v7MUNMarTRwDBoB36OipFaMEEqLg-iVLJSkpJxmtG3O3RuR-jUFOyow1rtRWfg_RYwwccYoFfGJr2xmkL2oShRm1pVrlX9q1Xtas3p6r_0_sChHN3m_n77Obis9kDmBQPKwFw
CitedBy_id crossref_primary_10_3892_br_2020_1310
crossref_primary_10_1016_j_biopha_2020_109818
crossref_primary_10_1016_j_ecoenv_2023_115122
crossref_primary_10_1016_j_jff_2018_02_005
crossref_primary_10_1016_j_lfs_2022_121131
crossref_primary_10_1016_j_jss_2021_04_039
crossref_primary_10_1021_acs_jafc_9b04323
crossref_primary_10_1016_j_jsps_2018_07_005
crossref_primary_10_3892_ijmm_2018_3830
crossref_primary_10_1016_j_envpol_2021_117080
crossref_primary_10_1016_j_psj_2021_101441
crossref_primary_10_3389_fphar_2019_00509
crossref_primary_10_1007_s11033_022_07661_1
crossref_primary_10_1038_s41598_021_93196_7
crossref_primary_10_3390_antiox9080706
crossref_primary_10_1089_jmf_2021_0134
crossref_primary_10_1038_s41598_024_60848_3
Cites_doi 10.1016/j.jhep.2010.08.011
10.1152/ajpgi.00001.2006
10.1111/j.1600-0773.1995.tb00993.x
10.1021/pr0606326
10.1126/science.179.4073.588
10.1016/0304-4165(79)90289-7
10.1177/11.1.102
10.1016/j.jtusci.2013.01.002
10.1021/bi00510a001
10.1016/S0021-9258(18)57306-3
10.1016/S0021-9258(19)45228-9
10.1006/abbi.2000.2035
10.1093/jnci/djm037
10.1113/jphysiol.2003.049478
10.1016/j.fct.2008.07.016
10.1016/S0010-4655(98)00016-2
10.1124/mol.64.5.1136
10.1179/096805104225004879
10.1016/0008-8749(81)90411-1
10.1371/journal.pone.0050778
10.1021/bi971894b
10.1016/S0006-2952(96)00605-3
10.1016/S0891-5849(02)00740-2
10.1016/j.ejphar.2008.11.054
10.1007/s00198-006-0205-z
10.1093/bioinformatics/bti770
10.1007/s10495-011-0659-0
10.1016/j.phrs.2007.01.012
10.1016/j.fct.2008.10.026
10.1042/bj0520185
10.1016/j.ejphar.2011.01.030
10.1016/S0021-9258(19)77815-6
10.1016/j.cbi.2007.10.005
10.1093/nar/gkn314
10.1007/s11883-009-0065-z
10.1007/s11418-011-0544-8
10.1021/bi00039a035
10.1016/S0021-9258(18)93963-3
10.1177/09680519010070050501
10.1002/jcc.21256
10.1136/gut.30.6.854
10.3390/ijms14036306
10.1016/S2221-1691(13)60009-X
10.1016/j.ejphar.2011.12.027
10.1016/j.cbi.2008.09.036
10.1016/0003-2697(79)90738-3
10.1016/S0021-9258(19)52451-6
10.1002/pros.21190
10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6
10.1016/0076-6879(67)10018-9
10.1007/s10620-007-9994-y
10.3109/10715762.2011.564168
10.1016/S0021-9258(19)42083-8
10.1016/0076-6879(69)13016-5
10.1016/S0378-4274(99)00062-4
10.1007/BF00769730
10.33549/physiolres.932041
10.3109/13880209.2013.803579
10.1002/lt.21931
10.1016/S0304-3940(99)00593-5
ContentType Journal Article
Copyright Copyright © 2017 American Chemical Society
Copyright_xml – notice: Copyright © 2017 American Chemical Society
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7S9
L.6
DOI 10.1021/acs.jproteome.7b00176
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList AGRICOLA
MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
EISSN 1535-3907
EndPage 3199
ExternalDocumentID 28758404
10_1021_acs_jproteome_7b00176
b980481941
Genre Journal Article
GroupedDBID -
53G
55A
5GY
7~N
AABXI
ABMVS
ABUCX
ACGFS
ACS
AEESW
AENEX
AFEFF
ALMA_UNASSIGNED_HOLDINGS
AQSVZ
CS3
DU5
EBS
ED
ED~
EJD
F5P
GNL
IH9
IHE
JG
JG~
P2P
RNS
ROL
UI2
VF5
VG9
W1F
ZA5
---
4.4
5VS
AAHBH
AAYXX
ABBLG
ABJNI
ABLBI
ABQRX
ADHLV
AHGAQ
BAANH
CITATION
CUPRZ
GGK
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7S9
L.6
ID FETCH-LOGICAL-a384t-c8b6f903e346bdce5902e99de21159a2777ce10caf99297fe9e5639076b89b673
IEDL.DBID ACS
ISSN 1535-3893
1535-3907
IngestDate Fri Jul 11 07:23:44 EDT 2025
Thu Jul 10 17:01:35 EDT 2025
Wed Feb 19 02:42:52 EST 2025
Thu Apr 24 23:01:45 EDT 2025
Tue Jul 01 01:05:37 EDT 2025
Thu Aug 27 13:41:54 EDT 2020
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords electron transport
free radicals
TCA Cycle
lipid peroxidation
ATP
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a384t-c8b6f903e346bdce5902e99de21159a2777ce10caf99297fe9e5639076b89b673
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 28758404
PQID 1924904231
PQPubID 23479
PageCount 10
ParticipantIDs proquest_miscellaneous_2067270539
proquest_miscellaneous_1924904231
pubmed_primary_28758404
crossref_citationtrail_10_1021_acs_jproteome_7b00176
crossref_primary_10_1021_acs_jproteome_7b00176
acs_journals_10_1021_acs_jproteome_7b00176
ProviderPackageCode JG~
55A
AABXI
GNL
VF5
7~N
VG9
W1F
ACS
AEESW
AFEFF
ABMVS
ABUCX
IH9
AQSVZ
ED~
UI2
CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20170901
2017-09-01
2017-Sep-01
PublicationDateYYYYMMDD 2017-09-01
PublicationDate_xml – month: 09
  year: 2017
  text: 20170901
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of proteome research
PublicationTitleAlternate J. Proteome Res
PublicationYear 2017
Publisher American Chemical Society
Publisher_xml – name: American Chemical Society
References ref9/cit9
Misra H. P. (ref23/cit23) 1972; 247
ref45/cit45
ref3/cit3
ref63/cit63
ref56/cit56
ref16/cit16
ref52/cit52
ref8/cit8
ref59/cit59
ref2/cit2
Meister A. (ref51/cit51) 1988; 263
Lekić N. (ref62/cit62) 2011; 60
ref34/cit34
ref37/cit37
ref48/cit48
ref60/cit60
ref17/cit17
ref10/cit10
Padma P. (ref42/cit42) 1997; 34
ref35/cit35
ref53/cit53
ref19/cit19
ref21/cit21
Mehler A. H. (ref30/cit30) 1948; 174
ref46/cit46
Tretter L. (ref58/cit58) 1987; 19
ref49/cit49
ref13/cit13
ref61/cit61
King J. C. (ref27/cit27) 1965
ref50/cit50
ref54/cit54
ref6/cit6
ref36/cit36
ref18/cit18
ref11/cit11
ref25/cit25
ref29/cit29
ref32/cit32
ref39/cit39
ref14/cit14
ref57/cit57
ref5/cit5
ref43/cit43
ref28/cit28
ref40/cit40
Lowry O. H. (ref20/cit20) 1951; 193
Farber J. L. (ref38/cit38) 1990; 62
ref26/cit26
ref55/cit55
ref12/cit12
ref15/cit15
Habig W. H. (ref24/cit24) 1974; 249
ref41/cit41
ref22/cit22
ref33/cit33
ref4/cit4
ref47/cit47
ref1/cit1
Minakami S. (ref31/cit31) 1962; 237
ref44/cit44
ref7/cit7
References_xml – ident: ref2/cit2
  doi: 10.1016/j.jhep.2010.08.011
– ident: ref52/cit52
  doi: 10.1152/ajpgi.00001.2006
– ident: ref41/cit41
  doi: 10.1111/j.1600-0773.1995.tb00993.x
– ident: ref4/cit4
  doi: 10.1021/pr0606326
– ident: ref26/cit26
  doi: 10.1126/science.179.4073.588
– ident: ref25/cit25
  doi: 10.1016/0304-4165(79)90289-7
– ident: ref32/cit32
  doi: 10.1177/11.1.102
– ident: ref14/cit14
  doi: 10.1016/j.jtusci.2013.01.002
– ident: ref44/cit44
  doi: 10.1021/bi00510a001
– volume: 174
  start-page: 961
  year: 1948
  ident: ref30/cit30
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(18)57306-3
– volume: 247
  start-page: 3170
  year: 1972
  ident: ref23/cit23
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(19)45228-9
– ident: ref17/cit17
  doi: 10.1006/abbi.2000.2035
– ident: ref11/cit11
  doi: 10.1093/jnci/djm037
– ident: ref59/cit59
  doi: 10.1113/jphysiol.2003.049478
– start-page: 363
  volume-title: Practical Clinical Enzymology
  year: 1965
  ident: ref27/cit27
– ident: ref48/cit48
  doi: 10.1016/j.fct.2008.07.016
– ident: ref36/cit36
  doi: 10.1016/S0010-4655(98)00016-2
– ident: ref50/cit50
  doi: 10.1124/mol.64.5.1136
– ident: ref5/cit5
  doi: 10.1179/096805104225004879
– ident: ref22/cit22
  doi: 10.1016/0008-8749(81)90411-1
– ident: ref63/cit63
  doi: 10.1371/journal.pone.0050778
– ident: ref47/cit47
  doi: 10.1021/bi971894b
– ident: ref18/cit18
  doi: 10.1016/S0006-2952(96)00605-3
– ident: ref43/cit43
  doi: 10.1016/S0891-5849(02)00740-2
– ident: ref53/cit53
  doi: 10.1016/j.ejphar.2008.11.054
– ident: ref12/cit12
  doi: 10.1007/s00198-006-0205-z
– ident: ref35/cit35
  doi: 10.1093/bioinformatics/bti770
– ident: ref61/cit61
  doi: 10.1007/s10495-011-0659-0
– ident: ref8/cit8
  doi: 10.1016/j.phrs.2007.01.012
– ident: ref1/cit1
  doi: 10.1016/j.fct.2008.10.026
– ident: ref29/cit29
  doi: 10.1042/bj0520185
– ident: ref60/cit60
  doi: 10.1016/j.ejphar.2011.01.030
– volume: 263
  start-page: 17205
  year: 1988
  ident: ref51/cit51
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(19)77815-6
– ident: ref57/cit57
  doi: 10.1016/j.cbi.2007.10.005
– ident: ref37/cit37
  doi: 10.1093/nar/gkn314
– ident: ref9/cit9
  doi: 10.1007/s11883-009-0065-z
– ident: ref39/cit39
  doi: 10.1007/s11418-011-0544-8
– ident: ref40/cit40
  doi: 10.1021/bi00039a035
– volume: 237
  start-page: 569
  year: 1962
  ident: ref31/cit31
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(18)93963-3
– ident: ref6/cit6
  doi: 10.1177/09680519010070050501
– ident: ref34/cit34
  doi: 10.1002/jcc.21256
– volume: 62
  start-page: 670
  year: 1990
  ident: ref38/cit38
  publication-title: Lab Invest.
– ident: ref49/cit49
  doi: 10.1136/gut.30.6.854
– ident: ref54/cit54
  doi: 10.3390/ijms14036306
– ident: ref15/cit15
  doi: 10.1016/S2221-1691(13)60009-X
– ident: ref56/cit56
  doi: 10.1016/j.ejphar.2011.12.027
– ident: ref46/cit46
  doi: 10.1016/j.cbi.2008.09.036
– ident: ref21/cit21
  doi: 10.1016/0003-2697(79)90738-3
– volume: 193
  start-page: 265
  year: 1951
  ident: ref20/cit20
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(19)52451-6
– ident: ref10/cit10
  doi: 10.1002/pros.21190
– ident: ref33/cit33
  doi: 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6
– ident: ref19/cit19
  doi: 10.1016/0076-6879(67)10018-9
– ident: ref7/cit7
  doi: 10.1007/s10620-007-9994-y
– ident: ref13/cit13
  doi: 10.3109/10715762.2011.564168
– volume: 249
  start-page: 7130
  year: 1974
  ident: ref24/cit24
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(19)42083-8
– ident: ref28/cit28
  doi: 10.1016/0076-6879(69)13016-5
– ident: ref55/cit55
  doi: 10.1016/S0378-4274(99)00062-4
– volume: 34
  start-page: 296
  year: 1997
  ident: ref42/cit42
  publication-title: Indian J. Biochem. Biophys.
– volume: 19
  start-page: 21
  year: 1987
  ident: ref58/cit58
  publication-title: J. Bioenergy Biomembr.
  doi: 10.1007/BF00769730
– volume: 60
  start-page: 549
  year: 2011
  ident: ref62/cit62
  publication-title: Physiol. Res.
  doi: 10.33549/physiolres.932041
– ident: ref16/cit16
  doi: 10.3109/13880209.2013.803579
– ident: ref3/cit3
  doi: 10.1002/lt.21931
– ident: ref45/cit45
  doi: 10.1016/S0304-3940(99)00593-5
SSID ssj0015703
Score 2.3270118
Snippet Functional perturbation of mitochondria is associated with fulminant hepatic failure (FHF). d-Galactosamine/lipopolysaccharide (d-GalN/LPS)-induced FHF is a...
SourceID proquest
pubmed
crossref
acs
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 3190
SubjectTerms adenosine triphosphate
Adenosine Triphosphate - agonists
Adenosine Triphosphate - antagonists & inhibitors
Adenosine Triphosphate - biosynthesis
albino
Animals
antioxidant activity
Antioxidants - chemistry
Antioxidants - pharmacology
Binding Sites
body weight
Carotenoids - chemistry
Carotenoids - pharmacology
Chemical and Drug Induced Liver Injury - drug therapy
Chemical and Drug Induced Liver Injury - metabolism
Chemical and Drug Induced Liver Injury - pathology
Citric Acid Cycle - drug effects
electron transport chain
Electron Transport Chain Complex Proteins - agonists
Electron Transport Chain Complex Proteins - antagonists & inhibitors
Electron Transport Chain Complex Proteins - metabolism
enzyme activity
enzymes
Galactosamine - toxicity
hydrogen peroxide
Hydrogen Peroxide - antagonists & inhibitors
Hydrogen Peroxide - metabolism
lipid peroxidation
Lipid Peroxidation - drug effects
lipid peroxides
Lipopolysaccharides - toxicity
Lipoxygenase Inhibitors - chemistry
Lipoxygenase Inhibitors - pharmacology
Lipoxygenases - chemistry
Lipoxygenases - metabolism
Liver
liver failure
Liver Failure, Acute - chemically induced
Liver Failure, Acute - drug therapy
Liver Failure, Acute - metabolism
Liver Failure, Acute - pathology
lungs
lycopene
Male
mitochondria
Mitochondria - drug effects
Mitochondria - metabolism
Mitochondria - pathology
mitochondrial membrane
Molecular Docking Simulation
molecular models
neoplasms
Oxidative Stress
Protein Binding
Protein Interaction Domains and Motifs
Protein Structure, Secondary
proteome
Rats
Rats, Wistar
toxicity
tricarboxylic acid cycle
Title Lycopene Prevents Mitochondrial Dysfunction during d‑Galactosamine/Lipopolysaccharide-Induced Fulminant Hepatic Failure in Albino Rats
URI http://dx.doi.org/10.1021/acs.jproteome.7b00176
https://www.ncbi.nlm.nih.gov/pubmed/28758404
https://www.proquest.com/docview/1924904231
https://www.proquest.com/docview/2067270539
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9RADB6VcoAL78fy0iBxQkqa17yO1cKyQgUhoFJv0WTGkbZss1WTPWxPHLnyF_kl2JNkJYRWhWsU5zFjjz_L9mfGXgmncwylZSTBi6hIbRpZIWzka6itziubuVDl-1HOj4v3J-Jkjx3syOBn6YF1bXwaSAtWZxCrELXIa-x6JtGQCQtNv2zTBkQn1ROkiog88diys-sx5JJc-6dL2oEzg7-Z3Wafxq6dvszkW7zuqthd_k3i-K-_cofdGrAnP-yV5S7bg-YeuzEdR77dZz-ONtSk0gAfmJ1a_gEtHk_IxpOi8jeblhwhbSbvGxy5__X95zu7pLE9rT0j1o2jxTlNXti01lFP18JDRANCHHiOAW9fesPnQKXcjs_sggrj-aLhh0uM0lf8s-3aB-x49vbrdB4Noxoim-uii5yuZG2SHPJCVp5au5IMjPGA8aUwNlNKOUgTZ2uDeEzVYEAgNkqUrLSppMofsv1m1cBjxjXKOq19UlhVOFAWAWklc-trI7zO6wl7jetYDqbWliGLnqVluDgubjks7oQV49aWbiA9p9kby6vE4q3Yec_6cZXAy1FvStwzSrrYBlZr_DwKcKn4KN19Txby4Xgcmgl71Cvd9rUY0SJGTIon__PbT9nNjOBHqIV7xva7izU8R_DUVS-CwfwG9ccb7w
linkProvider American Chemical Society
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LbxMxELZKOZQL70eggJE4ITns049jFAgB0h6gFb2tvLZXCqSbCm8O4cSRa_9if0lnvLtBIEVVr9ba68fY841m5htCXudGpmBKc8adzVkW65jpPNfMVq7SMi11YkKU7yGfHmefTvKTHcL7XBiYhIeRfHDi_2UXiN9i2_fAXbA8dUMRjBd-g9wEQJKgZI_GXzfeA2SVanlSc4YKuc_c2TYMaibj_9VMW-BmUDuTO-TbZsIh2uTHcNWUQ_PrPy7H66_oLrndIVE6akXnHtlx9X2yN-4LwD0gf2ZrTFmpHe14njw9gPsP72VtUWzpu7VHtYhHS9t0R2ovfp9_0Ass4uP1KXJwzOZnWIdh7bXBDK-5dQzLhRhnKZi_bSAOnToM7DZ0oucYJk_nNR0twGZf0i-68Q_J8eT90XjKusINTKcya5iRJa9UlLo046XFRK8ocUpZB9ZmrnQihDAujoyuFKAzUTnlckBKkeClVCUX6SOyWy9r94RQCX2NlDbKtMiMExrgaclTbSuVW5lWA_IG9rHoLp4vgk89iYvQ2G9u0W3ugGT9CRemo0DHShyLq7oNN93OWg6Qqzq86sWngDNDF4yu3XIF00NzF0OR4u3fJME7Do-jGpDHrextfgv2LSDGKHt6nWW_JHvTo4NZMft4-PkZuZUgMAlRcvtkt_m5cs8BVjXli3CHLgGV5yRQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELZgkYDLLm_K8jASJySXvPzIsepSCpQVAlZaiUPk2I5U6KYVTg_dE0eu_EV-CTNOUgmkagVXK3b8GHtmNN98Q8gzblQKrrRgwlnOsljHTHOuma1cpVVa6sQElO-xmJ5kb075aYeqxFwYmISHkXwI4uOtXtmqYxiIX2D7l8BfsDxzQxkcGHGZXMHQHUr3aPxxG0FAZqmWK5UzVMp99s6uYVA7Gf-ndtphcgbVMzkgn7eTDoiTr8N1Uw7N-V98jv-3qhtkv7NI6agVoZvkkqtvkWvjvhDcbfJjtsHUldrRju_J03fwDsC7WVsUX3q08age8Yhpm_ZI7a_vP1_pBRbz8foMuThm8xXWY9h4bTDTa24dw7IhxlkKbnALyKFThwBvQyd6jnB5Oq_paAG--5J-0I2_Q04mLz-Np6wr4MB0qrKGGVWKKo9Sl2aitJjwFSUuz60Dr5PnOpFSGhdHRlc5WGmycrnjYDFFUpQqL4VM75K9elm7-4Qq6GuUslGmZWac1GCmliLVtsq5VWk1IM9hH4vuAvoixNaTuAiN_eYW3eYOSNafcmE6KnSsyLG4qNtw223VcoFc1OFpL0IFnBmGYnTtlmuYHrq9CEmKd3-ThCg5PJL5gNxr5W_7W_BzwXKMsgf_suwn5Or7o0kxe3389pBcT9A-CWC5h2Sv-bZ2j8C6asrH4Rr9BrywJtM
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Lycopene+Prevents+Mitochondrial+Dysfunction+during+d-Galactosamine%2FLipopolysaccharide-Induced+Fulminant+Hepatic+Failure+in+Albino+Rats&rft.jtitle=Journal+of+proteome+research&rft.au=Sheriff%2C+Sheik+Abdulazeez&rft.au=Shaik+Ibrahim%2C+Shaikhussain&rft.au=Devaki%2C+Thiruvengadam&rft.au=Chakraborty%2C+Sandipan&rft.date=2017-09-01&rft.issn=1535-3907&rft.eissn=1535-3907&rft.volume=16&rft.issue=9&rft.spage=3190&rft_id=info:doi/10.1021%2Facs.jproteome.7b00176&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1535-3893&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1535-3893&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1535-3893&client=summon